Partner with a CRO team specialized in cell therapy clinical trial design and oversight

Your company is pioneering a new therapeutic modality that could revolutionize care for patients with cancer, autoimmune disorders and genetic disorders. You need a stable, trusted CRO partner that understands the unique needs of a cell therapy clinical trial. And one that can drive a clinical trial execution that is on schedule and within budget.

Our CIBMTR CRO Services set your cell therapy clinical trial up for success and help you mitigate risk.

Our contract research organization team focuses only on cell therapy and hematopoietic stem cell transplant (HSCT) clinical trial design and execution.

REQUEST AN INFORMATIONAL CALL

 

Leverage our years of experience in cell therapy and HSCT trials and correlative study management

0
+

years of clinical trials experience

0
+

patients and donors enrolled in clinical trials since 2001

0

active clinical studies in design, enrollment and follow-up

0
+

active studies under IND/IDE

NEARLY
0

Domestic transplant center investigational site partners

 

Translate complex cell therapy study designs into operational excellence

With a staff trained in the hematology/oncology therapeutic space, we have extensive capabilities to provide a truly customized support package that best fits your needs. Our CIBMTR CRO Services capabilities include:

  • Protocol development and approvals

  • Site selection, start-up and management

  • Study monitoring

  • Lab and research sample oversight

  • Patient-reported outcomes

  • Project management

  • Database build and data management

  • Statistics and data analysis

  • Contracts and financial administration

  • Medical and safety monitoring

Capabilities

Choose full clinical trial support or contract with our team to fill a gap in specific services, such as:

  • Support with surveys
  • Site selection and management
  • Sample management

 

Benefit from our unique infrastructure and extensive clinical trial site network

Because the CIBMTR is a research affiliation between the National Marrow Donor Program® (NMDP)/Be The Match and the Medical College of Wisconsin, you leverage a powerhouse of support and the established infrastructure and stability that goes along with it.

We are both a sponsor running our own clinical trials and a CRO running trials for other organizations. Our research organization is embedded within the operations of the NMDP/Be The Match. That means you benefit from the synergies with the NMDP/Be The Match and Be The Match BioTherapies® for:

  • End-to-end clinical trial design, operations and logistics support

  • Built-out clinical infrastructure with single Institutional Review Board (sIRB), dedicated Data Safety Monitoring Board (DSMB), master contracts and 21 CFR part 11 compliant technology

  • Access to patients and allogeneic donors for research

  • A direct link to the CIBMTR Outcomes Database with information on more than 575,000 patients

Active investigational transplant center sites in our clinical trials network

CRO map

We harness established relationships with a contracted network of nearly 250 investigational transplant center sites as well as donor center and research lab partners across the United States.

Our established relationships and contracts with investigational sites allow us to successfully recruit sites to participate on trials, complete site start up faster and expedite processes throughout the duration of the study.

Put our experience and expertise to work for you.

Let’s start with a conversation so we can learn more about your company’s needs.

 

Optimize clinical trial protocol design with clinical insight advisors

Our team is driven by our organizational mission—to save more lives through cellular therapy. Our in-house HSCT and cell therapy physicians offer clinical insights to help you optimize your protocol design and lay the groundwork for a successful clinical trial.

Our 70+ person CRO Services team is experienced in cell therapy and HSCT clinical trials.

CIBMTR CRO Services Leadership and Medical Team

Jeffery Auletta

Erin Leckrone

Senior Director, Clinical Trials

Lisa Erickson

Lisa Erickson

Senior Manager, Clinical Project Management

Kathleen Kane Headshot

Kathleen Kane

Senior Manager, Clinical Operations

Kelsey Schertz Headshot

Kelsey Schertz

Manager, Clinical Data Management

Caitrin Bupp Headshot

Caitrin Bupp

Manager, Biostatistics

Alisha Mussette

Alisha Mussetter

Manager, Clinical Monitoring Operations

Danielle O’Donnell Vitali

Danielle O’Donnell Vitali

Manager, Clinical Operations

Ashley Spahn Headshot

Ashley Spahn

Manager, Clinical Sample Management

Deb Mattila headshot

Deborah Mattila

Manager, Survey Research

Kayla Christianson

Kayla Christianson

Supervisor, Clinical Operations

Steven Devine, MD Chief Medical Officer Senior Scientific Director

Steven Devine, MD

Chief Medical Officer NMDP/Be The Match

Senior Scientific Director CIBMTR NMDP

Jeffery Auletta

Jeffery Auletta, MD

Senior Vice President, Patient Outcomes and Experience NMDP/Be The Match

Chief Scientific Director CIBMTR NMDP

Heather Stefanski, MD, PhD Vice President, Medical Services

Heather Stefanski, MD, PhD

Vice President, Medical Services NMDP/Be The Match

Scientific Director of Donor Health & Safety Working Committee CIBMTR NMDP

Access additional services for allogeneic cell therapy developers

BTM_B2B_Icon_Consulting_Blue

Bioinformatics Consulting

Access data-driven insights to help you define your targets, build your allogeneic cell bank and manage risk throughout cell therapy development.

Allogeneic Cell Sourcing

Allogeneic Cell Sourcing

Source high-quality adult donors that match your therapy needs and receive end-to-end support from donor identification through cell delivery.

Collection Network Onboarding

Cord Blood Unit Sourcing

Get comprehensive visibility and streamlined access to the fully characterized domestic cord blood unit inventory.

We’re ready to connect with you

Let’s discuss your needs and how our CIBMTR CRO Services professionals can support your cell and gene therapy trials.